Skip to main content

The use of herbal and dietary supplement among community-dwelling elderly in a suburban town of Malaysia



The use of herbal and dietary supplement (HDS) in health and disease management has gained global attention. HDS are generally accepted by the public and are associated with positive health behaviours. However, several reports have been documented with regards to their potential adverse effects and interaction with conventional medicines. Limited data is currently available on the use of HDS among elderly population in Malaysia. This present study aims to investigate the prevalence of and pattern of HDS use among a sample of community-dwelling elderly in a suburban town in Malaysia.


A cross-sectional survey was conducted between March and May 2019 among the elderly aged ≥60 years old. The participants with the following criteria were included in the study: aged ≥60 years, residing in Puncak Alam and able to understand Malay or English language. Data were collected using a pre-validated questionnaire. All statistical analysis was conducted using IBM SPSS ver. 23.


Overall, 336 out of 400 elderly responded to the survey, achieving a response rate of 84%. This study observed that almost 50% of the respondents were using at least one type of HDS in the past one month of the survey. Among HDS non-users, most of them preferred to use modern medicines (62.6%, 114/182). Among the HDS users, 75.3% (116/154) were using at least one type of modern medicine (prescription or over-the-counter medicine). Multivariate analysis showed that having good to excellent perceived health (adjusted OR = 2.666, 95% CI = 1.592–4.464), having felt sick at least once in the past one month (adjusted OR = 2.500, 95% CI = 1.426–4.383), and lower body mass index (adjusted OR = 0.937, 95% CI = 0.887–0.990) were associated with HDS use. It was noted that only a small percentage of HDS users (16.2%, 25/154) had informed healthcare providers on their HDS use.


The use of HDS is common among the elderly sampled. Hence, healthcare providers should be more vigilant in seeking information of HDS use for disease management in their elderly patients. Campaigns that provide accurate information regarding the appropriate use of HDS among the elderly are pertinent to prevent misinformation of the products.

Peer Review reports


Complementary and alternative medicine (CAM) is a broad term that covers non-mainstream practices of healthcare such as “natural products” (herbal and dietary supplements [HDS]) and “mind and body practices” [1]. The use of HDS has steadily increased over the years in many countries worldwide [2]. In a previous nationally representative survey among Malaysians, 87.3 and 88.9% of the respondents were reported to use biological-based therapies (including HDS) to maintain health and treat health problems, respectively [3]. Furthermore, HDS were commonly used by patients to manage chronic diseases [4] such as diabetes mellitus and dyslipidemia, and to maintain health [5].

The use of CAM was associated with several benefits among elderly which includes positive behaviour, which was reported among CAM users such as better confidence, empowerment, knowledge, and control relating to their health [6]. A systematic review by Bishop and colleagues showed that CAM users were more proactive in participating in treatment decisions, practice active coping strategy and were more in control of their health [7]. CAM or HDS are perceived as products that are safer with lesser side effects compared to modern medicines [7, 8]. Previous studies have associated several factors with HDS use among the elderly population such as female gender [4, 9,10,11], higher education [4, 9, 11,12,13], higher income [9, 11], ethnicity [9, 13], older age [9], use of other medications [12], and engagement in healthy lifestyles [14].

Despite the associated benefits and the perceived safety of HDS, there were concerns with the use of the products especially among the elderly [15]. HDS were shown to exert pharmacological effects due to the chemical moieties that they contain, consequently resulting in adverse effects [16]. In a report based on the 2004–2013 data from 63 hospitals in the United States (US), elderly aged 65 years or more were found to be more likely to be hospitalized due to adverse effects of dietary supplements (DS) compared to younger adults [17]. A subsequent surveillance survey reported hospitalization rates for emergency department (ED) visits due to adverse events associated with herbal medicine (HM) and DS, with data showing 10 and 12.9%, respectively [18]. It was also noted that 1.2 and 1.1% of 42,585 ED visits were due to adverse events caused by HM and DS, respectively [18].

The use of HDS has been implicated with adverse effects such as liver dysfunction [15] and nephropathy [19]. Elderlies with multiple comorbidities and usage of conventional medicines were shown to experience higher risk of adverse effects from HDS due to age-related physiological changes that affect the pharmacokinetics and pharmacodynamics of drugs consumed [20]. Case reports on HDS-drug interactions showed altered bioavailability of drugs which results in either increased risk of toxicity or reduced efficacy of conventional medicines [21]. This raises concern as elderlies are frequent users of medicines (i.e., prescriptions and over-the-counter) [22], as well as multiple types of HDS [15, 23]. In a study by Levy and colleagues, HDS-drug or HDS-HDS interactions were implicated for hospitalizations of 3.7% of all inpatients who used HDS [16].

High prevalence of HDS use among the elderly was reported in Western countries [24,25,26,27]. However, reports of HDS use among elderly in Asian countries are limited [4], and among Malaysian elderly is scarce [8]. Information gathered from previous studies conducted in other countries may not be applicable to the elderly in Malaysia. Therefore, the objectives of this present study were: (1) to investigate the prevalence of HDS use, including the types used, reasons of use, sources of obtainment, expenditure on HDS, sources of HDS information, and the disclosure to healthcare providers; (2) to examine the predictors of HDS use; and (3) to analyze the pattern of use (i.e., frequency, and purposes of use), and experience from use of each HDS utilized by a sample of community-dwelling elderly in a suburban town in Malaysia.


Study design and sample population

A cross-sectional study was conducted among a sample of community-dwelling elderly in Puncak Alam, a main suburban township in Kuala Selangor District, State of Selangor, Malaysia. Elderly were defined as those aged 60 years and above [28]. Elderly aged 60 years and older were recruited between March and May 2019. The participants with the following criteria were included in the study: aged ≥60 years, residing in Puncak Alam and able to understand Malay or English language. Exclusion criteria includes elderly who had cognitive or mental health problems or who refused to participate in the survey. The sample size was calculated using the Raosoft sample size calculator [29]. A sample size of 334 was recommended for a margin of error of 5%, confidence interval of 95%, and response distribution of 50% for an approximate total population of 2500 elderly in Puncak Alam [30]. This study was approved by the Research Ethics Committee of Universiti Teknologi MARA (UiTM), Malaysia (600-IRMI.5/1/6).

Survey instrument

The questionnaire was developed based on inputs from previous studies (Appendix 1). The survey instrument was reviewed by five academic pharmacists who had experience in survey research and in studies related to CAM or HDS to assess the relevance and suitability of each survey item. The questionnaire was also tested in a small convenient sample of elderly (n = 10) to assess for the clarity and comprehensibility of survey items. Feedbacks obtained from the academic pharmacist reviewers and the elderly respondents in the pre-testing phase were used to improve the survey items. The pilot test showed that the survey took approximately 20–30 min.

In this study, HDS refers to natural preparations (crude) and processed products (in the form of pills, capsules, tablets, powder, and liquids) that contain plant-derived materials; or products containing dietary ingredients such as vitamins, minerals, amino acids, and substances such as enzymes, organ tissues, glands, metabolites, extracts and concentrates taken orally to treat and/or prevent diseases or maintain health in the past one month [31, 32].

The first part of the questionnaire collects important demographic details of the respondents (e.g., age, gender, race, etc.). The respondents were also asked to indicate whether they have been diagnosed with any medical condition. For those who answered “yes” were asked to state the medical conditions that they have been diagnosed with. Subsequently, the questionnaire collects details about current conventional medicine use and HDS use in the past one month. For those who answered “yes” for HDS use, they were asked about the specific type of HDS that they were using, and the frequency of use. A list of common HDS is outlined in the survey instrument. The interviewer recorded by hand the name of HDS if it is not listed in the questionnaire. The respondents were also asked about their purpose of using HDS whether to treat minor illness, to treat chronic illness, to prevent disease or to maintain health. If the respondents mentioned that they used HDS to treat minor and chronic illnesses or to prevent disease, they were further asked to state the type of disease that they intend to treat or prevent. In addition, the respondents were asked to report any positive experience (any favourable outcomes) or negative experience (any unfavourable outcomes) from HDS use. If the respondents answered that they experienced any negative effect from HDS use, they were further asked to state the negative effect. The reasons for not using HDS were obtained from the non-users whereas the users were asked about the reasons that influenced them to use the products. Respondents who were using HDS were asked if they had ever disclosed their HDS use to their healthcare providers.

Data collection

Throughout the study period, 400 elderly were approached. The elderly respondents were selected using convenience sampling method in which potential respondents were approached at public places (e.g., supermarkets, malls, places of worship, post offices, etc.) and were asked for their interests to participate in the study. Potential respondents were screened for inclusion criteria and if eligible, were provided with a consent form to be signed. The method of interviewer-administered questionnaire was utilized as the participants were elderly who might have difficulties in self-administering the questionnaire. One research team member (MHZ) conducted all interviews to ensure a standard practice in the interview. The participation of the elderly in the study was voluntary and they were offered anonymity and confidentiality. No incentive was provided to the study participants.

Statistical analysis

All statistical analysis was conducted using IBM SPSS ver. 23. Continuous data were presented as mean and standard deviation (SD), whereas categorical data were presented as frequency and percentage. The percentage of categorical variables was compared using the Chi-squared test or Fisher’s exact test, and continuous data were compared using the independent samples t-test. As recommended by Hosmer et al. [33], variables with a P value of 0.20 were analyzed using logistic regression analysis to assess the association between independent variables and the use of HDS. Odds ratios (ORs) and 95% confidence intervals (CI) were reported for the logistic regression analysis. Statistical significance was established if the P value was < 0.05.


Socio-demographic characteristics of respondents

Table 1 shows the socio-demographic characteristics of the study respondents. Overall, 400 elderly were approached in the study and 336 responded to the survey, achieving a response rate of 84%. The sample met the minimum recommended sample size for this study. Those who refused to participate in the survey mentioned busyness and lack of interest as the reasons. Most of the respondents were female (224/336, 66.7%). The mean (± SD) age of the respondents was 63.57 ± 2.94, with many of them falling in the 60–65 age group (228/336, 67.9%).

Table 1 Socio-demographic characteristics of study respondents and comparison of the socio-demographic characteristics among HDS users and non-users

Among the elderly sample, 46.1% (155/336) was diagnosed with a medical condition. About 77% (258/336) of the respondents were using at least one type of medicine (prescription or over-the-counter [OTC]) at the point of survey. Approximately 50% (179/336) of the respondents perceived their health as “good – excellent”. However, about 69% (231/336) of the elderly reported that they had felt sick for at least once in the past one month. Self-reported underlying conditions of the respondents are outlined in Table 2. The most common medical conditions among the elderly respondents were hypertension (64/336, 19%), diabetes mellitus (43/336, 12.8%), and hypercholesterolemia (21/336, 6.3%). The use of HDS was significantly associated with elderly having hypertension, osteoarthritis, sinusitis, and tonsillitis.

Table 2 Underlying medical conditions among respondents

Factors associated with HDS use

Overall, 45.8% (154/336) of respondents were using at least one type of HDS at the point of survey. Table 1 shows the comparison of the socio-demographic characteristics of the HDS users and non-users. The univariate analysis showed that monthly income, perceived health status, history of sickness in the past one month, physical activities, and body mass index were associated with HDS use (Table 1). Multivariate analysis showed that having good – excellent perceived health (adjusted OR = 2.666, 95% CI = 1.592–4.464), a history of sickness in the past one month (adjusted OR = 2.500, 95% CI = 1.426–4.383), having lower body mass index (adjusted OR = 0.937, 95% CI = 0.887–0.990) were predictors of HDS use (Table 3).

Table 3 Factors associated with the use of HDS by logistic regression analysis (n = 336)

Among HDS non-users (182/336, 54.2%), the most common reasons for not using HDS include the preference for modern medicine (114/182, 62.6%), having no interest in using HDS (108/182, 59.3%), and the perception that HDS was too expensive (69/182, 37.9%) (Table 4).

Table 4 Non-users’ reasons for not using HDS (n = 182)

Details about HDS use among users

Table 5 shows the details of HDS use among the users. At the point of survey, 206 HDS products were used by 154 elderly. The average number (± SD) of HDS used by the users was 1.34 ± 0.55 (range = 1–3). Of the users, 69.5% (107/154) were using one type of HDS whereas 30.5% (47/154) were using two or three types of HDS. The most common types of HDS used by users were vitamin C (60/154, 39%), honey (35/154, 22.7%), fish oil (15/154, 9.7%), glucosamine (14/154, 9.1%), traditional herbal preparation i.e. jamu / makjun (12/154, 7.8%), and vitamin B complex (12/154, 7.8%).

Table 5 HDS use among users (n = 154)

The common reasons that motivated users to use HDS include easy access to the products (139/154, 90.3%), affordable price (132/154, 85.7%), and recommendation from family and friends (127/154, 82.5%). Among all HDS users, only a small percentage of them (25/154, 16.2%) informed their HDS use to their healthcare providers. The top three sources of HDS cited by users were pharmacies (86/154, 55.8%), followed by family and friends (51/154, 33.1%), and supermarkets (34/154, 22.1%). The majority of HDS users (125/154, 81.2%) spent less than RM 100 a month for HDS products. HDS users mostly obtained information about HDS from family and friends (142/154, 92.2%), the Internet (59/154, 38.3%), and television (56/154, 36.4%).

Pattern and experience of use among HDS users

Of all 206 HDS products used by the users, the majority used the products daily (125/206, 60.7%) (Table 6). The products were mainly used to maintain health (173/206, 84%) or prevent diseases (86/206, 41.7%). About 25% (51/206) of these products were used to treat minor illnesses whereas 14.6% (30/206) were used to treat chronic diseases. Most of the products (194/206, 94.2%) were reported to produce positive results. Only a small percentage of the products (20/206, 9.7%) were reported to produce adverse effects. The common adverse effects reported included weight gain (n = 5), stomachache (n = 4), and frequent urination (n = 4) (see footnote in Table 6). Table 7 summarizes the reported use of HDS among the users.

Table 6 Pattern and experience of HDS use among users
Table 7 Reported use of HDS among users


The finding from this study reports the common use of HDS among Malaysian elderly with the prevalence of 45.8%. It was also noted that the use of at least one type of DS and one type of HM has the prevalence of 39.5 and 11.3%, respectively. To our knowledge, this is the first study conducted that focused on HDS use among a sample of community-dwelling elderly in a suburban town in Malaysia. Previous studies have been conducted in urban cities [8, 34, 35] and rural areas [35] with the prevalence of HDS use of 43–56.9%. The prevalence of HDS use in this study was comparatively similar to few studies conducted in Ghana [12], Australia [36] and US [37]. The prevalence was comparatively lower to that reported in several other US studies [24, 25, 38] and in a study in Germany [26]. Factors associated with HDS use among the elderly that have been reported in previous studies included female gender [4, 9,10,11], higher education [4, 9, 11,12,13], higher income [9, 11], ethnicity [9, 13], older age [9], use of other medications [12], and engagement in healthy lifestyles [14]. This present study showed that elderly who perceived their health as “good – excellent”, who had a history of sickness in the past one month or who had lower body mass index were more likely to use HDS. The discrepancies in the prevalence and factors associated with HDS use among elderly between studies could be due to various factors such as the study design, recall period, type of HDS included age group of study population, settings and location.

Similar to previous studies, HDS users in the present study were more health conscious, which was evident by the higher engagement in weekly physical activities [14, 39, 40]. However the non-significant finding on smoking history (i.e., current or former smoker) among HDS users in this study was contradictory from several other studies that showed CAM or HDS users were more likely to refrain from smoking [9, 14]. Past reports on former smokers in a large cohort of community-dwelling elderly in the Gingko Evaluation Memory (GEM) study showed that this group was associated with the use of specific vitamin and mineral supplement [41]. Current or former smoker was also associated with HDS use among young adults in the US [42] and was most likely to use HDS in Danish women [43]. It is possible that those with smoking history are more health conscious and may consider using HDS to improve their health status.

Despite the health-attentive behaviour observed in elderly HDS users, they were more likely to fall sick at least once in the past month. This finding was in agreement with other studies where the elderly were reported to experience higher number of physically and mentally unhealthy days among HDS users despite being more health conscious [14]. Similarly, reports of arthritis and/or depression/anxiety, and frequent doctor visits were noted in elderly CAM users who are engaged in exercises [39].

Our results suggest that HDS consumption is influenced by high motivation to maintain health and the desire to solve health problems as approximately 80% of the of the HDS users “want to try HDS” (see Table 5). Additionally, it was also observed that the majority of HDS products (84%) were used to maintain health and about 42% of the products were used to prevent diseases. These findings are noteworthy given the public health imperative that more people become proactive and motivated to take an active role in their health management.

The consumption of HDS may also be attributed to the marketing of the products via the media or word of mouth. This study reports the HDS products were either recommended (82.5%) or product information were received (92.2%) from family and friends. Media such as the internet, television, and newspapers were also cited as common sources of HDS information among the users. There is a concern that information obtained from family and friends, and popular media may not be reliable, and may be anecdotal in nature and misleading [44]. Of note, many of the reported purposes for HDS use either for prevention of diseases or treatment of common ailments and chronic diseases were either unproven or not supported by existing evidence (e.g., the use of apricot seed, honey, turmeric, and fish oil to prevent cancer; apple cider vinegar, vitamin C and honey to treat / prevent diabetes mellitus; colostrum supplement to treat migraine and osteoarthritis) (see Table 7). This finding suggests that elderly who used HDS may not be well-informed or have been misled about the products. It is worth noting that although approximately 56% of HDS users obtained their HDS products from the pharmacies, only about 23% reported “pharmacists” as their source of information for their use of HDS. This finding suggests that communication about HDS among pharmacists and HDS customers at the pharmacy is minimal. Factors influencing the HDS users not to consider pharmacists as their preferred source of HDS information warrants further investigation.

The present study showed that 38.3 and 61% of HDS users were using prescription and OTC medicines, respectively. The prevalence of use of at least one type of medicine (prescription or OTC) was high at 75.3%. Our results emulate findings from a previous study that reported 68% of elderly were using OTC and HDS in addition to their prescribed medicines [10]. In another study among elderly patients with depression and/or dementia, 75% of the HDS users were also noted to be taking other medications including psychotropic and psychoactive drugs [45]. Furthermore, in the GEM study cohort, 90% of elderly who used HDS were also found to be using prescription medicine [24]. Concurrent use of HDS and conventional medicines should be a cause for concern due to the potential risk of HDS-drug interactions. The information on the clinical importance of HDS-drug interactions is limited. However, these interactions may potentially result in altered bioavailability or efficacy, or enhanced toxicity of conventional medicines [20].

A concern arose from this study as well as other reported studies [4, 46,47,48,49] is the non-disclosure of HDS consumption by users to their healthcare providers. A study by Mitha et al. also reported the absence of consultation with healthcare professional before using the treatment modalities among elderly CAM users [8]. This is an issue as without such disclosure, healthcare providers may not have the opportunity to assess the appropriateness of HDS use, detect HDS-related problems (e.g., toxicity, interactions, etc.) or provide professional advice regarding its use. Based on previous surveys that included HDS as part of CAM, the common reasons for non-disclosure of CAM use to healthcare providers include the lack of time to discuss about CAM [50], “healthcare providers did not ask” [14, 50, 51] and being unsure about the necessity or the importance of disclosure [14, 50].

Despite the safety concerns related to HDS use, our study showed that the HDS users were generally satisfied with the products. From 206 HDS products used in this study, 94.2% were claimed to produce positive effects which is in agreement with previously reported studies [14, 52, 53]. In a study conducted among elderly Japanese and American outpatients, CAM was even perceived as more effective than the treatment prescribed by physicians [54]. Similarly, in a survey among a sample of elderly in Malaysia, 55.1% of the respondents believed that CAM were more effective than modern medicines [8]. Moreover, only about 10% of HDS products in the study were implicated with negative experience. There are at least two possible explanations for these findings. First, HDS use may promote overall health (rather than focusing on illness), resulting in positive perceived outcomes among the users. Secondly it is also possible that HDS users are less wary about the potential adverse effects of HDS thus neglecting possible reactions.

High satisfaction from HDS use may result in abandoning prescribed medicine among HDS users [55]. Of note, in this present study, HDS was used to treat chronic diseases such as hypertension and diabetes mellitus. However, this study did not capture the rate of non-compliance of HDS users to their prescribed medicines. Therefore, it is unknown whether the use of HDS affects medications adherence. Hence, it is important for healthcare providers to remain cognizant of HDS use among the elderly so that the use of proven conventional therapies is not delayed or abandoned.

High satisfaction from HDS use among the respondents implies a general acceptance of the products among the elderly population [2]. The findings from this study suggest the use of HDS among the elderly may continue to be widespread which is currently seen in other developed countries [24, 26, 27]. The widespread use of HDS reported in our study warrants the on-going campaign to educate the public about HDS benefits and risks. There is also a pressing need for healthcare providers to continue learning about HDS and to integrate HDS in their professional practices [56].


The present study has several limitations. First, being a cross-sectional study, it only provides a snapshot of pattern of HDS use among the sample of elderly at the point of survey. As demonstrated in the study by Goh and colleagues, the pattern of HDS use among elderly may change (i.e., increased or decreased) over time [57]. Furthermore, the use of HDS and other data collected (including medical conditions and medication use) were self-reported. It is likely that respondents under- or over-estimate their use of HDS and other information. In addition, the study did not assess the dosage form, and the amount of intake or dose of each HDS the users were taking. Additionally, although we identified that 75.3% of elderly were using at least one type of medicine (prescription or OTC) with HDS, we did not assess the presence of HDS-drug interactions. Lastly, although the study met the recommendation for the minimum sample size, the sample of elderly recruited was from only one suburban town. The recruitment of elderly sample from only one geographical region limits the generalization of our study findings. The use of HDS may be different if similar study is conducted in metropolitan or rural areas. It is also possible that those who responded to the survey might be more interested in HDS (although were not using it), predisposing the results of this study to sampling bias. Future studies may be carried out in a bigger population of elderly individuals and from multiple sites.


HDS use was common among the elderly sample in this study. The elderly in general had positive experience with using the products. Even so, several concerns about HDS use in the study sample were noted. Our study findings showed that HDS were being concomitantly used with prescribed or OTC medicines. The rate of disclosure on HDS use to the healthcare providers was low. It was observed that easy access to HDS products, its affordability and recommendations from family and friends may have influenced the elderly to use HDS. HDS users were also noted to use unscientific source of information on HDS. Therefore, healthcare providers especially the pharmacists should be vigilant of the use of HDS in the elderly and actively play bigger roles in ensuring the safe and appropriate use of HDS in this population. Given that the elderly generally did not disclose their HDS use, this information should be solicited by healthcare providers while providing patient care services. Additionally, healthcare providers such doctors and pharmacists must equip themselves with adequate knowledge on HDS so that they can provide advice on safe and appropriate use of HDS to the consumers.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.



Complementary and alternative medicine


Confidence intervals


Dietary supplement


Emergency department


Gingko Evaluation Memory


Herbal and dietary supplement


Herbal medicine


Odds ratio




Standard deviation


United States


  1. 1.

    Complementary, Alternative, or Integrative Health: What’s in a Name? Accessed 12 March 2021.

  2. 2.

    Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, Kaye AD. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J. 2012;12(1):45–56.

    PubMed  PubMed Central  Google Scholar 

  3. 3.

    Siti Z, Tahir A, Farah AI, Fazlin SA, Sondi S, Azman A, et al. Use of traditional and complementary medicine in Malaysia: a baseline study. Complement Ther Med. 2009;17(5–6):292–9.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Masumoto S, Sato M, Maeno T, Ichinohe Y, Maeno T. Factors associated with the use of dietary supplements and over-the-counter medications in Japanese elderly patients. BMC Fam Pract. 2018;19(1):20.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Hasan SS, Ahmed SI, Bukhari NI, Loon WCW. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract. 2009;15(3):152–7.

    Article  PubMed  Google Scholar 

  6. 6.

    Canaway R, Manderson L. Quality of life, perceptions of health and iiiness, and complementary therapy use among people with type 2 diabetes and cardiovascular disease. J Altern Complement Med. 2013;19(11):882–90.

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Bishop FL, Yardley L, Lewith GT. A systematic review of beliefs involved in the use of complementary and alternative medicine. J Health Psychol. 2007;12(6):851–67.

    Article  PubMed  Google Scholar 

  8. 8.

    Mitha S, Nagarajan V, Babar MG, Siddiqui MJA, Jamshed SQ. Reasons of using complementary and alternative medicines (CAM) among elderly Malaysians of Kuala Lumpur and Selangor states: an exploratory study. J Young Pharm. 2013;5(2):50–3.

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Ness J, Cirillo DJ, Weir DR, Nisly NL, Wallace RB. Use of complementary medicine in older Americans: results from the health and retirement study. Gerontologist. 2005;45(4):516–24.

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867–78.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Chen S-Y, Lin J-R, Kao M-D, Hang C-M. The usage of dietary supplements among elderly individuals in Taiwan. Asia Pac J Clin Nutr. 2005;14:3.

    CAS  Google Scholar 

  12. 12.

    Aryeetey RN, Tamakloe SM. Use of dietary and herbal supplements among 623 elderly Ghanaians in the Keta municipality. J Hum Nutr Food Sci. 2015;3(4):1072.

  13. 13.

    Arcury TA, Quandt SA, Bell RA, Vitolins MZ. Complementary and alternative medicine use among rural older adults. Complement Health Pract Rev. 2002;7(3):167–86.

    Article  Google Scholar 

  14. 14.

    Cheung CK, Wyman JF, Halcon LL. Use of complementary and alternative therapies in community-dwelling older adults. J Alternat Complement Med. 2007;13(9):997–1006.

    Article  Google Scholar 

  15. 15.

    Nisly NL, Gryzlak BM, Zimmerman MB, Wallace RB. Dietary supplement polypharmacy: an unrecognized public health problem? Evid Based Complement Alternat Med. 2010;7(1):107–13.

    Article  PubMed  Google Scholar 

  16. 16.

    Levy I, Attias S, Ben-Arye E, Goldstein L, Schiff E. Adverse events associated with interactions with dietary and herbal supplements among inpatients. Br J Clin Pharmacol. 2017;83(4):836–45.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Geller AI, Shehab N, Weidle NJ, Lovegrove MC, Wolpert BJ, Timbo BB, et al. Emergency department visits for adverse events related to dietary supplements. N Engl J Med. 2015;373(16):1531–40.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidle NJ, Budnitz DS. US emergency department visits for outpatient adverse drug events, 2013-2014. JAMA. 2016;316(20):2115–25.

    Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Chau W, Ross R, Li J, Yong TY, Klebe S, Barbara JA. Nephropathy associated with use of a Chinese herbal product containing aristolochic acid. Med J Aust. 2011;194(7):367–8.

    Article  PubMed  Google Scholar 

  20. 20.

    Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol. 2007;21(3):217–30.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Kinsella LJ, Grossberg GT, Prakash N. Drug-Dietary Interactions: Over-the-Counter Medications, Herbs, and Dietary Supplements. In: Clinical Psychopharmacology for Neurologists. Springer; 2018. p. 213–24.

  22. 22.

    Hanlon JT, Fillenbaum GG, Ruby CM, Gray S, Bohannon A. Epidemiology of over-the-counter drug use in community dwelling elderly. Drugs Aging. 2001;18(2):123–31.

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Canter PH, Ernst E. Herbal supplement use by persons aged over 50 years in Britain. Drugs Aging. 2004;21(9):597–605.

    Article  PubMed  Google Scholar 

  24. 24.

    Nahin RL, Pecha M, Welmerink DB, Sink K, DeKosky ST, Fitzpatrick AL. Investigators GEoMS: concomitant use of prescription drugs and dietary supplements in ambulatory elderly people. J Am Geriatr Soc. 2009;57(7):1197–205.

    Article  PubMed  Google Scholar 

  25. 25.

    Cohen RJ, Ek K, Pan CX. Complementary and alternative medicine (CAM) use by older adults: a comparison of self-report and physician chart documentation. J Gerontol A-Biol Sci Med Sci. 2002;57(4):M223–7.

    Article  PubMed  Google Scholar 

  26. 26.

    Schnabel K, Binting S, Witt CM, Teut M. Use of complementary and alternative medicine by older adults–a cross-sectional survey. BMC Geriatr. 2014;14:1.

    Article  Google Scholar 

  27. 27.

    Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473–82.

    Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Zawawi R. Active ageing in Malaysia. Malaysia: The second meeting of the committee on international cooperation on active ageing; 2013.

    Google Scholar 

  29. 29.

    Raosoft®Sample Size Calculator. Accessed 12 March 2021.

  30. 30.

    Official Portal of District / Land Office of Kuala Selangor. Accessed 12 March 2021.

  31. 31.

    Questions and Answers on Dietary Supplements. Accessed 12 March 2021.

  32. 32.

    General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. Accessed 12 March 2021.

  33. 33.

    Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. New York: Wiley; 2013.

    Google Scholar 

  34. 34.

    Lim LM, McStea M, Chung WW, Azmi NN, Aziz SAA, Alwi S, et al. Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia. PLoS One. 2017;12(3):1–18.

    CAS  Google Scholar 

  35. 35.

    Neoh CF, Long CM, Lim SM, Ramasamy K, Shahar S, Majeed ABA. Medication use and adherence among multi-ethnic community dwelling older adults in Malaysia. Geriatr Gerontol Int. 2017;17(8):1–7.

    Article  Google Scholar 

  36. 36.

    Brownie S. Predictors of dietary and health supplement use in older Australians. Aust J Adv Nurs. 2006;23(3):267.

    Google Scholar 

  37. 37.

    Sebastian RS, Cleveland LE, Goldman JD, Moshfegh AJ. Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes. J Am Diet Assoc. 2007;107(8):1322–32.

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Gordon NP, Schaffer DM. Use of dietary supplements by female seniors in a large northern California health plan. BMC Geriatr. 2005;5(1):4.

    Article  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Astin JA, Pelletier KR, Marie A, Haskell WL. Complementary and alternative medicine use among elderly persons: one-year analysis. J Gerontol Med Sci. 2000;55:M4–9.

    CAS  Article  Google Scholar 

  40. 40.

    Cherniack EP, Senzel RS, Pan CX. Correlates of use of alternative medicine by the elderly in an urban population. J Alternat Complement Med. 2001;7(3):277–80.

    CAS  Article  Google Scholar 

  41. 41.

    Nahin RL, Fitzpatrick AL, Williamson JD, Burke GL, DeKosky ST, Furberg C, et al. Use of herbal medicine and other dietary supplements in community-dwelling older people: baseline data from the ginkgo evaluation of memory study. J Am Geriatr Soc. 2006;54(11):1725–35.

    Article  PubMed  Google Scholar 

  42. 42.

    Gardiner P, Kemper KJ, Legedza A, Phillips RS. Factors associated with herb and dietary supplement use by young adults in the United States. BMC Complement Altern Med. 2007;7(1):39.

    Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Knudsen VK, Rasmussen LB, Haraldsdóttir J, Ovesen L, Bülow I, Knudsen N, et al. Use of dietary supplements in Denmark is associated with health and former smoking. Public Health Nutr. 2002;5(3):463–8.

    Article  PubMed  Google Scholar 

  44. 44.

    Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol. 2005;23(12):2645–54.

    Article  PubMed  Google Scholar 

  45. 45.

    Kales HC, Blow FC, Welsh DE, Mellow AM. Herbal products and other supplements: use by elderly veterans with depression and dementia and their caregivers. J Geriatr Psych Neur. 2004;17(1):25–31.

    Article  Google Scholar 

  46. 46.

    Flack JM, Peters R, Mehra VC, Nasser SA: Hypertension in special populations. Cardiol Clin 2002; 20(2):303–319, vii, DOI:

  47. 47.

    Ernst E. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer. 1998;83(4):777–82.<777::AID-CNCR22>3.0.CO;2-O.

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Quandt SA, Chen H, Grzywacz JG, Bell RA, Lang W, Arcury TA. Use of complementary and alternative medicine by persons with arthritis: results of the National Health Interview Survey. Arthritis Care Res. 2005;53(5):748–55.

    Article  Google Scholar 

  49. 49.

    Saydah SH, Eberhardt MS. Use of complementary and alternative medicine among adults with chronic diseases: United States 2002. J Altern Complement Med. 2006;12(8):805–12.

    Article  PubMed  Google Scholar 

  50. 50.

    Complementary and alternative medicine. What people 50 and older are using and discussing with their physicians. Washington: AARP; 2007.

    Google Scholar 

  51. 51.

    Zhang AL, Xue CC, Lin V, Story DF. Complementary and alternative medicine use by older Australians. Ann N Y Acad Sci. 2007;1114(1):204–15.

    Article  PubMed  Google Scholar 

  52. 52.

    Cuellar N, Aycock T, Cahill B, Ford J. Complementary and alternative medicine (CAM) use by African American (AA) and Caucasian American (CA) older adults in a rural setting: a descriptive, comparative study. BMC Complement Altern Med. 2003;3(1):8.

    Article  PubMed  PubMed Central  Google Scholar 

  53. 53.

    Cherniack EP, Pan CX. Alternative and complementary medicine for elderly veterans: why and how they use it. Altern Complement Ther. 2002;8(5):291–4.

    Article  Google Scholar 

  54. 54.

    Flaherty JH, Takahashi R, Kim J-I, Habib S, Ito M, Matsushita S. Use of alternative therapies in older outpatients in the United States and Japan: prevalence, reporting patterns, and perceived effectiveness. J Gerontol A Biol Sci Med Sci. 2001;56(10):M650–5.

    CAS  Article  PubMed  Google Scholar 

  55. 55.

    Binns CW, Lee MK, Lee AH. Problems and prospects: public health regulation of dietary supplements. Annu Rev Public Health. 2018;39(1):403–20.

    Article  PubMed  Google Scholar 

  56. 56.

    Gabay M, Smith JA, Chavez ML, Goldwire M, Walker S, Coon SA, et al. White paper on natural products. Pharmacother. 2017;37(1):e1–e15.

    Article  Google Scholar 

  57. 57.

    Goh LY, Vitry AI, Semple SJ, Esterman A, Luszcz MA. Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly population. BMC Complement Altern Med. 2009;9(1):42.

    Article  PubMed  PubMed Central  Google Scholar 

Download references


The authors would like to thank the members of the Department of Pharmacy Practice, Universiti Teknologi MARA (UiTM) for their constructive feedback and ideas. Special thanks to Wan Nur Syamimi Wan Ismail for her assistance in data collection and data entry. Thank you to Dr. Yaman Walid Kassab for his advice on data analysis.


This study was self-funded by the authors.

Author information




MSAW, AAA and NO conceptualized the study and contributed to the development of the study design and methodology. MSAW, MFM, MHZ, MZM and HAH analyzed the data and interpreted the results. MSAW, AAA, and SM drafted the first manuscript draft. SS and NO provided extensive feedback to the draft. MSAW, SS, NO and SM finalized the manuscript for publication. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Mohd Shahezwan Abd Wahab or Sandra Maniam.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Research Ethics Committee of Universiti Teknologi MARA (UiTM), Malaysia (600-IRMI.5/1/6). Written informed consent was obtained from all participants and the study was conducted according to the ethical guidelines of the Helsinki Declaration.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wahab, M.S.A., Zaini, M.H., Ali, A.A. et al. The use of herbal and dietary supplement among community-dwelling elderly in a suburban town of Malaysia. BMC Complement Med Ther 21, 110 (2021).

Download citation


  • Complementary and alternative medicine
  • Elderly
  • Herbal and dietary supplement
  • Malaysia